Published in Gut on September 01, 1973
Survival and the immune response in patients with carcinoma of the colorectum. Gut (1979) 1.12
Large bowel cancer: causation and management. Gut (1975) 0.99
Leucocyte-migration-inhibition test in patients with colorectal cancer: clinicopathological correlations. Br J Cancer (1978) 0.91
Lymphokine activated killer (LAK) cells in patients with gastrointestinal cancer. Gut (1987) 0.84
Tumour immunology and the gut. Gut (1975) 0.84
The leucocyte adherence inhibtion test in cancer of the large bowel. Br J Cancer (1975) 0.81
Migration inhibition with various cell fractions in human colorectal cancer. Gut (1975) 0.81
A study of lymph nodes draining colorectal cancer using a two-stage inhibition of leucocyte migration technique. Gut (1975) 0.79
Inhibition of leucocyte migration in patients with large intestinal cancer by extracts prepared from large intestinal tumours and from normal colonic mucosa. Br J Cancer (1974) 0.78
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Discussion on major surgery in carcinoma of the rectum with or without colostomy, excluding the anal canal and including the rectosigmoid: general results of surgical treatment. Proc R Soc Med (1957) 12.44
Specific carcinoembryonic antigens of the human digestive system. J Exp Med (1965) 9.96
Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen. Br J Cancer (1972) 3.91
Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int J Cancer (1971) 3.06
Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma. Br Med J (1971) 2.82
Gastro-intestinal-specific antigen: an immunohistological and serological study. Br Med J (1962) 2.66
The biological activities of soluble lymphocyte products. Clin Exp Immunol (1972) 2.58
Cellular and humoral immunity to different types of human neoplasms. Nature (1968) 2.40
Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens. Proc Natl Acad Sci U S A (1969) 2.28
'Lymphokines': molecular mediators of cellular immune responses in animals and man. Proc R Soc Med (1970) 2.13
Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br Med J (1972) 1.84
Immunological reactivity in patients with carcinoma of colon. Br Med J (1971) 1.80
Carcinoembryonic antigen in faeces. Br Med J (1972) 1.71
Effect of autologous mammary tumour extracts on human leukocyte migration in vitro. Int J Cancer (1970) 1.38
Studies of colonic carcinoma antigens. Gut (1971) 1.27
Blocking effect of serum from tumor-bearing animals on macrophage migration inhibition with tumor antigens. J Immunol (1971) 1.27
Radioimmunoassay of carcinoembryonic antigen in extracts of human colon and stomach. Int J Cancer (1972) 1.23
Inhibition of migration of human autogenous and allogeneic leukocytes by extracts of patients' cancers. Cancer Res (1971) 1.22
Response of lymphocytes from patients with gastrointestinal cancer to the carcinoembryonic antigen of the human digestive system. Cancer (1971) 1.11
Prospective evaluation of laparoscopic-assisted colectomy in an unselected group of patients. Lancet (1992) 5.40
Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg (2010) 3.63
Mechanism and modification of rejection of heterografts between divergent species. Transplant Proc (1970) 2.63
Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut (2000) 2.56
Observer variation in clinical diagnosis--a computer-aided assessment of its magnitude and importance in 552 patients with abdominal pain. Methods Inf Med (1973) 2.42
Production of artificial "case histories" by using a small computer. Br Med J (1971) 2.41
Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. Surgery (1970) 2.38
Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut (1998) 2.36
Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med (1970) 2.33
Redefining the R1 resection in pancreatic cancer. Br J Surg (2006) 2.30
Action of gastrin on the lower oesophageal sphincter in man. Gut (1969) 2.06
Laparoscopic resection of colon Cancer: consensus of the European Association of Endoscopic Surgery (EAES). Surg Endosc (2004) 2.01
The response of general surgeons to HIV in England and Wales. Ann R Coll Surg Engl (1990) 1.89
Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg (2005) 1.89
A new technique for renal allograft biopsy. Br J Radiol (1987) 1.74
Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg (2001) 1.74
Laparoscopic omental patch repair of perforated duodenal ulcer with an automated stapler. Br J Surg (1993) 1.73
Deranged liver blood flow patterns in the detection of liver metastases. Br J Surg (1985) 1.73
Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg (1993) 1.68
Construction and uses of a 'data-base' of clinical information concerning 600 patients with acute abdominal pain. Proc R Soc Med (1971) 1.67
Comparison between peripherally implanted ports and externally sited catheters for long-term venous access. Ann R Coll Surg Engl (1994) 1.62
Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. Br J Cancer (2002) 1.62
Experience with surgical implantation of catheters for continuous ambulatory peritoneal dialysis. Ann R Coll Surg Engl (1985) 1.54
Cell viability studies on the exfoliated colonic cancer cell. Br J Surg (1978) 1.53
A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring. Cancer (1995) 1.52
Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol (2001) 1.48
Hazards of surgical treatment due to microorganisms in the bile. Surgery (1974) 1.46
Interaction of intravenous methylprednisolone with oral cyclosporin. Nephrol Dial Transplant (1990) 1.44
Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol (2000) 1.42
DNA aneuploidy in ulcerative colitis. Gut (1986) 1.38
Patient factors influencing conversion from laparoscopically assisted to open surgery for colorectal cancer. Br J Surg (2008) 1.37
Clinical heterotransplantation of the liver. Transplant Proc (1970) 1.35
Adhesions and incisional hernias following laparoscopic versus open surgery for colorectal cancer in the CLASICC trial. Br J Surg (2010) 1.35
Stimulation of the inflammatory system by reamed and unreamed nailing of femoral fractures. An analysis of the second hit. J Bone Joint Surg Br (1999) 1.33
DNA aneuploidy in colorectal adenomas. Br J Cancer (1986) 1.32
Hypophosphataemia: A complication of "innocuous dextrose-saline". Lancet (1976) 1.31
Randomized clinical trial of Ligasure versus conventional diathermy for day-case haemorrhoidectomy. Br J Surg (2002) 1.29
Cholecystectomy is safer without drainage: the results of a prospective, randomized clinical trial. Surgery (1991) 1.29
The lateral paramedian incision--experience with 850 cases. Br J Surg (1982) 1.27
Gastric secretion stimulated by meat extract in man. Scand J Gastroenterol (1966) 1.26
Vertical abdominal incisions--a choice? Br J Surg (1980) 1.24
Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis. Br J Surg (1985) 1.23
Lymphocyte transformation in the mesenteric lymph nodes of patients with Crohn's disease. Gut (1973) 1.21
An early assessment of selective and total vagotomy. Br J Surg (1968) 1.20
Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand/Fas interaction. Br J Cancer (2004) 1.20
Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice. Ann Surg (1998) 1.18
Improving the detection of hepatic metastases by the use of dynamic flow scintigraphy. Br J Cancer (1983) 1.18
A comparison of reports from referees chosen by authors or journal editors in the peer review process. Ann R Coll Surg Engl (2000) 1.17
Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol (1992) 1.16
Decreased interleukin-2 production in patients with gastrointestinal cancer. Br J Surg (1986) 1.11
Continuous intravenous pentagastrin as a stimulant of maximal gastric acid secretion. Gut (1969) 1.11
The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases. Br J Cancer (2007) 1.10
Short-term costs of conventional vs laparoscopic assisted surgery in patients with colorectal cancer (MRC CLASICC trial). Br J Cancer (2006) 1.10
Laparoscopic sigmoid colectomy: total laparoscopic approach. Dis Colon Rectum (1994) 1.10
Suture length to wound length ratio and the integrity of midline and lateral paramedian incisions. Br J Surg (1991) 1.09
Biology of pancreatic cancer. Gut (1991) 1.09
Hyperacute rejection of renal homografts: with particular reference to coaglation changes, humoral antibodies, and formed blood elements. Transplant Proc (1971) 1.08
Effect of oesophageal perfusion with acid on basal gastric secretion. Gut (1968) 1.07
Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis. AJR Am J Roentgenol (1999) 1.07
Mirizzi's syndrome--results from a large western experience. HPB (Oxford) (2006) 1.07
Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer? Br J Cancer (1986) 1.06
Proceedings: A comparison of tumour sensitivity to cytostatic agents during in vivo and in vitro culture. Br J Surg (1976) 1.05
Monocyte activation after open and laparoscopic surgery. Br J Surg (1997) 1.05
Response of Pneumocystis carinii pneumonia only after high-dose cotrimoxazole. Lancet (1982) 1.05
Serum CRP and IL-6 levels after trauma. Not predictive of septic complications in 31 patients. Acta Orthop Scand (1998) 1.04
The postoperative insulin test--a further assessment. Br J Surg (1969) 1.04
The postoperative insulin test: failure to detect incomplete vagotomy in patients with high acid levels. Br J Surg (1968) 1.03
CAPD--a risk factor in renal transplantation? Br J Surg (1984) 1.03
Gut barrier function in malnourished patients. Gut (1998) 1.02
Altered taste thresholds in gastro-intestinal cancer. Clin Oncol (1980) 1.02
Alpha-globulins in the surveillance of colorectal cancer. Biomedicine (1976) 1.01
1997 Harry M. Vars Research Award. Does the route of feeding modify gut barrier function and clinical outcome in patients after major upper gastrointestinal surgery? JPEN J Parenter Enteral Nutr (1997) 0.99
Death from early colorectal cancer is predicted by the presence of transcripts of the REG gene family. Br J Cancer (2000) 0.98
Lack of correlation between failure of gut barrier function and septic complications after major upper gastrointestinal surgery. Ann Surg (2000) 0.98
The effect of transplantation on dialysis dementia. Proc Eur Dial Transplant Assoc (1979) 0.97
Validation of a self administered questionnaire to elicit gastrointestinal symptoms. Br Med J (Clin Res Ed) (1985) 0.96
Conservative surgery for bleeding peptic ulcer. Br Med J (1967) 0.96
The value of colonic exfoliative cytology in the diagnosis of carcinoma of the large intestine. Dis Colon Rectum (1977) 0.96
Aluminium accumulation and immunosuppression. BMJ (1989) 0.96
Cellular and muscle zinc in surgical patients with and without gastrointestinal cancer. Clin Sci (Lond) (1990) 0.95
Interleukin 13 and inflammatory markers in human sepsis. Br J Surg (2004) 0.95
The role of hypoxia in recurrence following resection of Dukes' B colorectal cancer. Int J Colorectal Dis (2008) 0.95
Stimulation of inflammatory markers after blunt trauma. Br J Surg (1998) 0.95
Primary adenocarcinoma in an ileostomy: a late complication of surgery for ulcerative colitis. Surgery (1993) 0.94
Effect of pH changes on the cardiac sphincter. Gut (1969) 0.94
Intraperitoneal haemorrhage from anterior abdominal wall varices. Postgrad Med J (1993) 0.93
Monitoring of renal allografts by Doppler ultrasound. Ann R Coll Surg Engl (1987) 0.93
Interleukin-10. A role in the development of postoperative immunosuppression. Arch Surg (1997) 0.93
Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer. Br J Cancer (1983) 0.92
Polymorphonuclear leukocyte activation. An early marker of the postsurgical sepsis response. Arch Surg (1993) 0.92
Tumour necrosis factor and bacterial sepsis. Br J Surg (1989) 0.92
Pathological scarring: strategic interventions. Eur J Surg (2002) 0.92
Laparoscopic herniorrhaphy: initial experience in 126 patients. J Laparoendosc Surg (1994) 0.91
The response of the lower oesophageal sphincter to a test-meal stimulus. Br J Surg (1973) 0.91
Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases. Br J Cancer (2000) 0.90